NEW YORK (GenomeWeb) – Emory University's School of Medicine and global testing firm Eurofins Scientific today announced they have entered into an agreement whereby Eurofins will acquire a controlling interest in the Emory Genetics Laboratory (EGL).

EGL is a part of the Department of Human Genetics and provides testing services for hospitals and other institutional clients. It specializes in next-generation sequencing testing, especially for rare genetic disorders, the university said in a statement.